-
Product Insights
Likelihood of Approval Analysis for Generalized Anxiety Disorder (GAD)
Overview How likely is it that the drugs in Generalized Anxiety Disorder (GAD) will get approved? Will the drugs transition to the next phase of its clinical pathway? This report provides you with the data that allows you to track and predict the specific likelihood of approval (LoA) and phase transition success rate (PTSR) of drugs using GlobalData’s proprietary machine learning algorithms developed using over 10 years of historical data. Generalized Anxiety Disorder (GAD) Overview Generalized anxiety disorder is a...
-
Product Insights
Likelihood of Approval Analysis for Dementia Associated With Alzheimer’s Disease
Overview How likely is it that the drugs in Dementia Associated With Alzheimer's Disease will get approved? Will the drugs transition to the next phase of its clinical pathway? This report provides you with the data that allows you to track and predict the specific likelihood of approval (LoA) and phase transition success rate (PTSR) of drugs using GlobalData’s proprietary machine learning algorithms developed using over 10 years of historical data. Dementia Associated With Alzheimer's Disease Overview Alzheimer's disease (AD)...
-
Product Insights
Likelihood of Approval Analysis for Lennox-Gastaut Syndrome
Overview How likely is it that the drugs in Lennox-Gastaut Syndrome will get approved? Will the drugs transition to the next phase of its clinical pathway? This report provides you with the data that allows you to track and predict the specific likelihood of approval (LoA) and phase transition success rate (PTSR) of drugs using GlobalData’s proprietary machine learning algorithms developed using over 10 years of historical data. Lennox-Gastaut Syndrome Overview Lennox-Gastaut syndrome (LGS) is a severe form of epilepsy...
-
Product Insights
Likelihood of Approval Analysis for Migraine
Overview How likely is it that the drugs in Migraine will get approved? Will the drugs transition to the next phase of its clinical pathway? This report provides you with the data that allows you to track and predict the specific likelihood of approval (LoA) and phase transition success rate (PTSR) of drugs using GlobalData’s proprietary machine learning algorithms developed using over 10 years of historical data. Migraine Overview Migraine is a genetically influenced complex neurological disorder characterized by episodes...
-
Product Insights
Likelihood of Approval and Phase Transition Success Rate Model – INV-400 in Major Depressive Disorder
Empower your strategies with our Likelihood of Approval and Phase Transition Success Rate Model - INV-400 in Major Depressive Disorder report and make more profitable business decisions.This report provides you with the data that allows you to track and predict the specific likelihood of approval (LOA) and phase transition success rate (PTSR) of a drug using GlobalData’s proprietary machine learning algorithms developed using over 10 years of historical data. INV-400 in Major Depressive Disorder Drug Details: INV-400 is under development...
-
Product Insights
Likelihood of Approval Analysis for Relapsing Remitting Multiple Sclerosis (RRMS)
Overview How likely is it that the drugs in Relapsing Remitting Multiple Sclerosis (RRMS) will get approved? Will the drugs transition to the next phase of its clinical pathway? This report provides you with the data that allows you to track and predict the specific likelihood of approval (LoA) and phase transition success rate (PTSR) of drugs using GlobalData’s proprietary machine learning algorithms developed using over 10 years of historical data. Relapsing Remitting Multiple Sclerosis (RRMS) Overview Relapsing-remitting multiple sclerosis...
-
Product Insights
NewLikelihood of Approval and Phase Transition Success Rate Model – CST-101 in Parkinson’s Disease
Empower your strategies with our Likelihood of Approval and Phase Transition Success Rate Model - CST-101 in Parkinson's Disease report and make more profitable business decisions.This report provides you with the data that allows you to track and predict the specific likelihood of approval (LOA) and phase transition success rate (PTSR) of a drug using GlobalData’s proprietary machine learning algorithms developed using over 10 years of historical data. CST-101 in Parkinson's Disease Drug Details: CST-10 is under development for the...
-
Product Insights
NewLikelihood of Approval and Phase Transition Success Rate Model – Levoxiracetam in Memory Impairment
Empower your strategies with our Likelihood of Approval and Phase Transition Success Rate Model - Levoxiracetam in Memory Impairment report and make more profitable business decisions.This report provides you with the data that allows you to track and predict the specific likelihood of approval (LOA) and phase transition success rate (PTSR) of a drug using GlobalData’s proprietary machine learning algorithms developed using over 10 years of historical data. Levoxiracetam in Memory Impairment Drug Details: L-oxiracetam is under development for the...
-
Product Insights
NewLikelihood of Approval and Phase Transition Success Rate Model – Levetiracetam ER in Psychosis
Empower your strategies with our Likelihood of Approval and Phase Transition Success Rate Model - Levetiracetam ER in Psychosis report and make more profitable business decisions.This report provides you with the data that allows you to track and predict the specific likelihood of approval (LOA) and phase transition success rate (PTSR) of a drug using GlobalData’s proprietary machine learning algorithms developed using over 10 years of historical data. Levetiracetam ER in Psychosis Drug Details: Levetiracetam ER (AGB-101) is under development...
-
Product Insights
Likelihood of Approval and Phase Transition Success Rate Model – NV-5138 in Treatment Resistant Depression
Empower your strategies with our Likelihood of Approval and Phase Transition Success Rate Model - NV-5138 in Treatment Resistant Depression report and make more profitable business decisions.This report provides you with the data that allows you to track and predict the specific likelihood of approval (LOA) and phase transition success rate (PTSR) of a drug using GlobalData’s proprietary machine learning algorithms developed using over 10 years of historical data. NV-5138 in Treatment Resistant Depression Drug Details: NV-5138 is under development...